Active Ingredients:
- Empagliflozin: An SGLT2 inhibitor that increases glucose excretion in the urine.
- Linagliptin: A DPP-4 inhibitor that enhances the body’s natural ability to regulate blood sugar levels.
Uses:
- Type 2 diabetes mellitus, as an adjunct to diet and exercise, to improve glycemic control.
How it Works:
- Empagliflozin: Works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine.
- Linagliptin: Increases the levels of incretin hormones, which stimulate insulin release and reduce glucagon production.
Important Considerations:
- Side Effects: Common side effects include urinary tract infections, genital infections, and hypoglycemia (low blood sugar).
- Drug Interactions: Empagliflozin and Linagliptin may interact with other medications, so it’s important to inform your doctor about all medications you are currently taking.
- Pregnancy and Breastfeeding: Consult your doctor before taking Erlina Tablets if you are pregnant or breastfeeding.
- Kidney Function: Monitor kidney function regularly, especially in patients with impaired kidney function.
Note: Always follow the instructions on the product label or consult a healthcare professional for specific advice.
